Health
Biological E. Limited gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate – United News of India
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed…
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC).BE started the Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate in the second week of November…
-
General22 hours agoUkraine threatens retaliation after Russian strikes on power grid
-
Noosa News18 hours agoStar Brisbane cricketer finds home in suburb with shocking popularity rise
-
General23 hours agoThe Global Sumud Flotilla sets sail to deliver aid to Gaza
-
Noosa News23 hours agoHome prices keep rising in ‘seller’s market’ as new property listings below average